Breaking News

Zydus Lifesciences to Enter the Global CDMO Business

Agrees to acquire two biologics manufacturing facilities from Agenus Inc. in California.

Author Image

By: Charlie Sternberg

Associate Editor

Zydus Lifesciences Ltd. plans to enter the global biologics contract development and manufacturing organization (CDMO) business by acquiring Agenus Inc.’s U.S.-based biologics CMC facilities. This acquisition marks Zydus’ strategic investment in U.S.-based manufacturing for biologics thereby adding a sustainable growth driver for the group. Agenus Inc. is a clinical-stage immuno-oncology company committed to developing immune therapies that effectively combat cancer. Under the ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters